drugset
drugset / Trial / NCT01146535

Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment

NCT01146535 ↗

Phase 2 Completed 40 enrolled Ainos, Inc. (f/k/a Amarillo Biosciences Inc. CytoPharm, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to evaluate the safety and effect of interferon-alpha lozenges when used in combination with oseltamivir (Tamiflu) to treat influenza.

Timeline

Start
2011-01
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule 75 mg —
Subject interferon alfa-2b Protein / enzyme biologic 150 iu —

Indications

influenza